This metabolic shift is impacted via the HIF1 pathway, which is of particular relevance in ccRCC, a disease in which the vast majority of tumors harbor a somatic alteration in the VHL gene. This evidence concerns the gene HIF1A and nonpapillary renal cell carcinoma.